Download your
Charcot Marie Tooth Disease
(CMT1A) booklet below!
Technical leaflet of our current CMT model available with the InnoSer portfolio
-
Model contains 3 to 4 copies of the human PMP22 gene
-
Evaluate the efficacy of your compound through multiple key endpoints available
-
View our CMT model and validation data
When it comes to successful CMT research, the first step to success is choosing the most applicable model to meet your research needs.
InnoSer provides in-house expertise in helping select the right model for your research goals and most appropriate endpoints that accelerate your research and can have a dramatic effect on the time, resources and dollars you put into achieving your research goals.